Advancing the National Immunization Program in an era of achieving universal vaccine coverage in China and beyond
CONCLUSION: The articles emphasize the need for government leadership, strategic policymaking, and public awareness to enhance vaccine coverage and equity. The VaxLab will continue strengthening China's NIP by focusing on vaccine financing, emphasizing diversity, equity, and inclusion, and improving maternal vaccination coverage. Research will extend to Southeast Asian and Western Pacific regions, especially in middle-income countries facing challenges in vaccine financing and delivery. The collective efforts outlined in this collection show a commitment to evolving and adapting immunization strategies to meet global health goals and to provide equitable access to vaccines for all.PMID:38475849 | DOI:10.1186/s40249-024-01192-6
Source: Cancer Control - Category: Cancer & Oncology Authors: Shu Chen Lance E Rodewald Anna Heng Du Shenglan Tang Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Cervical Cancer Vaccine | China Health | Covid Vaccine | COVID-19 | Gardasil | Genital Warts | Haemophilus Influenzae (Hib) | Human Papillomavirus (HPV) | Indonesia Health | Influenza Vaccine | International Medicine & Public Health | Laboratory Medicine | Meningitis Vaccine | Pediatrics | Pneomococcal Vaccine | Rotavirus | Rotavirus Vaccine | Study | Vaccines | WHO